Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Genkyotex S.A
225
Genkyotex S.A
Technology
Biotechnology
Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.
Suggest edits
Founded
2006
Raised
$52.4M
Follow us
Also headquartered in Geneva
Seedstars
WHO
World Economic Forum
Seedstars World
Temenos
ProtonMail
CERN
Index Ventures
STMicroelectronics
Silent Circle
Companies in the same industry
MassChallenge
UWI Technology
ChromaDex
Personalis, Inc.
Perlstein Lab
VivoSight OCT
CDx Life
Codagenix
Rubicon Genomics
AlterG
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$21,000,000
Venture capital (Series D) - 2015
VI Partners
Neomed Management
Edmond de Rothschild Venture Capital
+3
$26,000,000
Venture capital (Series C) - 2012
MP Healthcare Venture Management
Edmond de Rothschild Venture Capital
Eclosion
+1
Team Size
1–10
Employees
I work here
Location
Geneva
,
Switzerland
Headquarters
Explore Geneva
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Genkyotex S.A makes some noise.
